73866-15-6 Usage
General Description
3-(1H-benzimidazol-1-yl)propan-1-amine is a chemical compound that belongs to the class of benzimidazole compounds. It consists of a benzimidazole group, which is a heterocyclic aromatic organic compound, attached to a propylamine group. 3-(1H-BENZIMIDAZOL-1-YL)PROPAN-1-AMINE has a molecular formula C11H14N4 and a molecular weight of 202.25 g/mol. It is used in pharmaceutical research and drug development due to its potential as a central nervous system agent and its ability to interact with specific receptors in the brain. 3-(1H-BENZIMIDAZOL-1-YL)PROPAN-1-AMINE has the potential to be used in the treatment of various neurological disorders and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 73866-15-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,8,6 and 6 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 73866-15:
(7*7)+(6*3)+(5*8)+(4*6)+(3*6)+(2*1)+(1*5)=156
156 % 10 = 6
So 73866-15-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H13N3/c11-6-3-7-13-8-12-9-4-1-2-5-10(9)13/h1-2,4-5,8H,3,6-7,11H2
73866-15-6Relevant articles and documents
MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)
-
Page/Page column 59; 110, (2020/01/08)
The present invention relates to compounds of formula (I) and salts, stereoisomers, tautomers or N-oxides thereof that are useful as modulators of STING (Stimulator of Interferon Genes). The present invention further relates to the compounds of formula (I) for use as a medicament and to a pharmaceutical composition comprising said compounds.
INDANE DERIVATES AS MUSCARINIC RECEPTOR AGONISTS
-
Page 40, (2010/02/10)
The present invention relates to compounds of Formula I: I which are agonists of the M-1 muscarinic receptor.
Inhibitors of glycogen synthase kinase 3
-
, (2008/06/13)
Novel pyridine and pyrimidine derivatives which selectively inhibit glycogen synthase kinase 3 are provided and methods of preparing these compounds are provided. These compounds are useful in treating certain conditions which may be mediated by glycogen synthase kinase 3.